Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 451
  • Print this page
  • Email this page

    Article Cited by others


Comparison of the Tellgenplex HPV DNA test with the PCR-reverse dot blot assay for human papillomavirus genotyping

Yao Ya-Chao, Li Nan, Hu Liang-Shan, Li Ya-Hong, Zhang Zhi

Year : 2018| Volume: 11| Issue : 2 | Page no: 141-146

   This article has been cited by
1 An insight into clinical and laboratory detections for screening and diagnosis of cervical cancer
Shruthi Padavu, Pooja Aichpure, Ballamoole Krishna Kumar, Anoop Kumar, RadhaKanta Ratho, Shipra Sonkusare, Indrani Karunasagar, Iddya Karunasagar, Praveen Rai
Expert Review of Molecular Diagnostics. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology
Wei Jiang, R Marshall Austin, Huina Zhang, Yanmei He, Lian Xu, Xiuli Wu, Wei Kuang, Lingling Tong, Lei Li, Chengquan Zhao
American Journal of Clinical Pathology. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Revealing the Disturbed Vaginal Micobiota Caused by Cervical Cancer Using High-Throughput Sequencing Technology
Yupei Xie,Ying Feng,Wenyu Li,Fuliang Zhan,Genhua Huang,Hui Hu,Yifei Xiong,Buzhen Tan,Tingtao Chen
Frontiers in Cellular and Infection Microbiology. 2020; 10
[Pubmed]  [Google Scholar] [DOI]


Read this article